Medical Services

Clinical Trials at Englewood Hospital: Oncology

- Please scroll down to view all studies -

Prostate Cancer

EHMC IRB Study #: E-12-459

Principal Investigator:
Dr. Eric Margolis
Tel: 201-816-4567
Email: emargomd@gmail.com

Study Coordinator:
Audrey Ades
Tel: 201-894-3603
Email: audrey.ades@ehmc.com

Sponsor:
National Cancer Institute - CALGB

Study Title:
70807: The Men’s Eating and Living (MEAL) Study: A Randomized Trial of Diet to Alter Disease Progression in Prostate Cancer Patients on Active Surveillance

Eligibility requirements:
Men who are between 50 - 80 years old with biopsy-proven prostate cancer who have not received any prior therapy.

Study objectives:
To determine if a telephone-based dietary intervention compared to no intervention will decrease clinical progression in patients undergoing "Active Surveillance" for prostate cancer.

Summary of procedures:
Patients will be randomly assigned to one of two treatment groups: (1) Patients in group one will receive dietary education, telephone counseling sessions, and detailed newsletters over 24 months; (2) Patients in group two will receive standard US Department of Agriculture dietary guidelines for Americans and general newsletters over 24 months.

*Each listing only contains a summary of the study information.  Please contact the Principal Investigator or Study Coordinator for the full details on a particular study.